XML 11 R13.htm IDEA: XBRL DOCUMENT v3.19.3
6. Equity
3 Months Ended
Jun. 30, 2019
Equity [Abstract]  
Equity

NOTE 6 - EQUITY

 

Preferred stock

 

There are 50,000,000 shares authorized as preferred stock, of which 40,000,000 are designated as Series B and 2,000,000 are designated as Series A. 8,000,000 shares have yet to be designated. All 2,000,000 shares of Series A preferred are issued and outstanding. Each share of Series A preferred is convertible into 240 shares of common stock. The Series A Preferred Stock votes with the Common Stock on all matters to be voted on by the common stock on an as-converted basis. On such matters, each holder of Series A Preferred Stock is entitled to 240 votes for each share of Series A Preferred Stock held by such shareholder.

 

Common stock

 

On April 23, 2019 the Company issued 4,000,000 shares of common stock in exchange for services valued at $25,600 or $0.0064 per share.

 

On May 14, 2019 the Company sold 1,562,500 shares of common stock for $10,000 or $0.0064 per share.

 

On May 25, 2019 the Company sold 11,718,750 shares of common stock for $75,000 or $0.0064 per share.

 

On June 1, 2019 the Company issued 67,000,000 shares of common stock in exchange for services valued at $428,800 or $0.0064 per share.

 

On June 1, 2019 the Company issued 6,000,000 shares of common stock in exchange for the acquisition of UCL MMA LLC valued at $38,400 or $0.0064 per share.

 

As part of the Pinnacle Combat LLC acquisition, the Company issued 8,000,000 shares of common stock valued at $51,200 or $0.0064 per share.